Skip to main content

Highlights

  1. 1
    Scientific reports · 2022
    PMID: 36587030PMCID: PMC9805452DOIFirst author25 citations
  2. 2
    Journal of neuropathology and experimental neurology · 2025
    PMID: 40261909PMCID: PMC13143185DOIeCommonsFirst author1 citations

Publications

54 publications

Funding

5 grants

Active

3 grants
  • Co-I
    Dual-[Hypoxia+Proliferation] PET as a Predictive Biomarker in Recurrent Glioblastoma
    National Cancer Institute · 2026–2031
    R01CA308323-01A1
  • Co-I
    Somatostatin Receptor 2 Expression in Pituitary Neuroendocrine Tumors as a Basis for PET/MRI guided Subtype Stratification and Radiotherapy Planning
    National Cancer Institute · 2025–2027
    R21CA289111-01A1
  • Co-I
    Development of novel preclinical models and therapeutics for ETMR
    Children's Cancer Research Fund · 2023–2026
    CCRF 226613-01
Completed grants (2)
  • Co-I
    State Selective Lethality: Exploiting a Previously Unrecognized Therapeutic Vulnerability in Glioblastoma
    William Rhodes Center for Glioblastoma - Collaborative Research Initiative · 2022–2023
    WRCG 223502-01
  • Co-I
    Machine Learning Approaches to Improve Histological Interpretation of Glioblastoma
    William Rhodes Center for Glioblastoma - Collaborative Research Initiative · 2020–2021
    WRCG 210432-01